Conjunctivitis Treatment Market Players:
- Novartis AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Aurobindo Pharma Limited
- Cipla Limited
- Viatris Inc.
- Akorn Operating Company LLC
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Dr.Reddy’s Laboratories Limited
- MICRO LABS LIMITED
- Ocular Therapeutix, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of conjunctivitis treatment is evaluated at USD 5.29 Billion.
The global conjunctivitis treatment market size was worth over USD 5.08 Billion in 2025 and is poised to grow at a CAGR of around 4.6%, reaching USD 7.96 Billion revenue by 2035.
North America conjunctivitis treatment market will hold over 36% share by 2035, driven by high corrective lens usage and healthcare infrastructure.
Key players in the market include Novartis AG, Aurobindo Pharma Limited, Cipla Limited, Viatris Inc., Akorn Operating Company LLC, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Dr.Reddy’s Laboratories Limited, MICRO LABS LIMITED, Ocular Therapeutix, Inc.
